| Predicate |
Object |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2004-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2006-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a38b3bc49f9d3470011006db286b2bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab06f5427139ab756ad64da05c889904
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0fa58cfa93a5c0c3c32515133dfafbb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d40960190e37af1e3390c21a67554f98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb270a420fbf05cb39d573b3125ff5a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80ea52df622383c2e8bba7e16c3787e7 |
| publicationDate |
2006-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2275637-C2 |
| titleOfInvention |
Method for predicting relapses in skin melanoma patients |
| abstract |
FIELD: medicine. n SUBSTANCE: method involves measuring daily estrone, estradiol and estriol excretion in women of reproductive age. Relation between estriol excretion and total amount of estrone and estradiol excretion after treatment and at control examination stage is calculated. The value being found to grow, relapse is predicted to occur in 11-12 months after the treatment. n EFFECT: high accuracy of prognosis; enhanced effectiveness of treatment. n 1 tbl |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2643761-C1 |
| priorityDate |
2004-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |